JUST IN: Abortion pill manufacturer sues FDA to keep drug on the market
on whether restrictions should be imposed on mifepristone, including potentially revoking the generic version's FDA authorization.the company brought the suit to prevent the FDA "from depriving GenBioPro of its constitutional and statutory right to market mifepristone.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
As Supreme Court Weighs Next Steps on Abortion Pill, Protesters Rally in Support of Abortion RightsAs the Supreme Court weighs its options on the abortion pill mifepristone, abortion and women’s rights supporters across the U.S. are protesting the latest efforts to restrict access to abortion.
Read more »
Anti-abortion groups urge US Supreme Court to restrict abortion pillThe U.S. Supreme Court should restrict the availability of the abortion pill mifepristone, anti-abortion groups challenging the medication's federal regulatory approval told the justices in a filing on Tuesday, urging them to implement curbs ordered by a conservative federal judge in Texas.
Read more »
Abortion opponents urge Supreme Court to allow limits on abortion drugSupreme Court justices are considering a request from the Biden administration and a New York-based drug company that manufactures the abortion drug mifepristone to delay lower-court rulings restricting its use.
Read more »
Abortion pill: Anti-abortion group urges Supreme Court to revive mifepristone restrictionsA coalition of anti-abortion groups asked the Supreme Court on Tuesday to reinstate restrictions on a common abortion pill called mifepristone a day before the high court is set to hand down a decision in the emergency appeal.
Read more »
Anti-abortion groups urge Supreme Court to restrict abortion pillAnti-abortion groups are urging the Supreme Court to implement curbs on abortion medication, as ordered by a conservative federal judge in Texas.
Read more »
Abortion-pill rulings could break the FDA, drug companies sayPharmaceutical companies have mobilized against a pair of lower-court rulings restricting access to abortion pills that they contend go far beyond issues of reproductive health and pose a threat to the regulatory foundations of the U.S. drug industry.
Read more »